Clinical Trials Browser

Myelodysplastic Syndromes, Myeloproliferative Disorders, Thrombocytopenia, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

NCT07025512 2026-04-16

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

Phase 2 Suspended

40 enrolled

Classical hematology

Cytopenia, Anemia, Thrombocytopenia

NCT06886516 2026-04-15

Apixaban in Thrombocytopenia

Phase EARLY_PHASE1 Recruiting

30 enrolled

Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT06521931 2026-03-02

A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients

Phase 1 Completed

24 enrolled

Classical hematology

Thrombocytopenia

NCT07441720 2026-03-02

Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)

Phase 2 Recruiting

25 enrolled

Classical hematology

Thrombocytopenia

NCT00975819 2026-01-06

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

Phase 2 Completed

61 enrolled 7 charts

Classical hematology

Tufted angioma, Lymphangioma, Thrombocytopenia

NCT02617745 2026-01-02

GLIOPLAK

Phase 2 Completed

244 enrolled

CNSClassical hematology

Glioblastoma, Thrombocytopenia

NCT05255003 2025-12-17

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Phase 4 Recruiting

50 enrolled

Classical hematology

Thrombocytopenia

NCT07257809 2025-12-02

Herombopag Treated T-DM1 Induced Platelet Reduction

Phase 2 Recruiting

56 enrolled

Classical hematology

Thrombocytopenia

NCT04526886 2025-10-06

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

Phase NA Completed

52 enrolled 8 charts

Classical hematologyGastrointestinal

Appendiceal Neoplasms, Esophageal Neoplasms, Neutropenia, Stomach Neoplasms, Thrombocytopenia, Colorectal Neoplasms

NCT07185893 2025-09-22

A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors

Phase NA Not yet recruiting

106 enrolled

Classical hematology

Neoplasms, Thrombocytopenia

NCT07110090 2025-09-09

Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)

Phase 1 Recruiting

16 enrolled

Classical hematology

Neoplasms, Thrombocytopenia

NCT04861181 2025-05-22

NIRAPK

Phase 4 Terminated

12 enrolled

Classical hematologyGynecologic

Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT01660347 2025-05-02

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

Phase NA Withdrawn

Classical hematologyOther hematologic neoplasm

Anemia, Lymphopenia, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

Clinical Trials

MYELO-CAN:TXA

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

Apixaban in Thrombocytopenia

A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients

Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

GLIOPLAK

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Herombopag Treated T-DM1 Induced Platelet Reduction

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors

Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)

NIRAPK

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant